The Structural Basis for the Immune Recognition of Factor VIII
The Structural Basis for the Immune Recognition of Factor VIII
批准号:
10406902
负责人:
John S. Lollar
金额:
$38.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2024-04-30
关键词:
AddressAntibodiesAntigen PresentationAntigen-Antibody ComplexAntigensB-Cell Antigen ReceptorBindingC2 DomainCollaborationsComplexCrystallizationDAG/PE-Binding DomainDeuteriumDevelopmentElectron MicroscopyElectronsEpitopesF8 geneFab ImmunoglobulinsFactor VIIIFc ReceptorHumanHydrogenImmuneImmune responseImmunodominant EpitopesImmunoglobulin GLengthMapsMass Spectrum AnalysisMethodsModelingMolecular WeightNegative StainingProtein AnalysisProteinsReceptor CellResolutionRoentgen RaysRoleSpectrum AnalysisStructureSurface Plasmon ResonanceSystemTestinganalytical ultracentrifugationexperienceimmunogenicityin vivoinhibitorparticleprotein complexprotein protein interactionsedimentation velocityskill acquisitionstoichiometryvon Willebrand Factor
中文摘要
摘要/摘要(项目一)
英文摘要
Summary/Abstract (Project 1)
The central hypothesis of this project is that intrinsic structural and dynamic features of fVIII are responsible for
its immunogenicity. The basis for this hypothesis is the remarkable immunogenicity of fVIII compared to other
proteins. Additionally, during the early immune response to fVIII, fVIII immune complexes may amplify the
immune response through Fc receptor or B cell receptor (BCR), antigen presentation or other mechanisms. To
address this hypothesis, a better understanding of the structures and dynamics of fVIII and fVIII immune
complexes is required. There are three Specific Aims in this project. Aim 1 is to develop X-ray crystallographic
structures of fVIII and fVIII immune complexes. Development of atomic level resolution X-ray structures of fVIII,
activated fVIII and fVIII immune complexes is fundamental to a better understanding of the immune response to
fVIII. The available fVIII X-ray structures are not at atomic level resolution. Structures of immune complexes of
the fVIII C2 domain are available. However, there are no structures of immune complexes with full-length or B
domain-deleted fVIII. We have developed a high-expression platform that yields sub-gram quantities of a fVIII
construct designated HP47 for crystallographic trials. In preliminary studies, we have crystals of HP47 fVIII that
diffract beyond 3.2 Å resolution and are refining the structure. Aim 2 is to characterize fVIII antibody epitopes
and fVIII immune complexes by hydrogen deuterium exchange mass spectrometry (HDX MS), electron
microscopy (EM) and surface plasmon resonance spectroscopy. These methods are state-of-the-art
complementary methods to characterize epitopes. HDX MS mapping studies of the C1 and C2 domain have
been performed by our group. We have now obtained HDX coverage of the ~ 250-kDa full-length fVIII molecule,
which will be used to map immunodominant epitopes throughout the fVIII molecule. Aim 3 is to characterize fVIII
immune complexes by sedimentation velocity analytical ultracentrifugation (SV AUC). IgG immune complexes
can amplify the immune response to the cognate antigen. However, the role of fVIII immune complexes in the
immune response to fVIII has not been explored. A combination of two or more IgG molecules that recognize
non-overlapping epitopes hypothetically can form large immune complexes with molecular weights extending to
megadaltons. SV AUC is the method of choice for identifying and characterizing large protein-protein complexes.
In preliminary studies, we have determined the stoichiometry of binary fVIII/anti-A2 MAb 4A4 and fVIII/anti-C2
MAb 3D12 complexes and the ternary fVIII/4A4/3D12 complex. These studies will be extended to characterize
the stoichiometries of immune complexes formed by additional important classes of anti-fVIII MAbs. X-ray
crystallographic, HDX MS, EM and SV AUC results be combined to develop models of fVIII IgG immune
complexes. Additionally, the immune complexes characterized in Aim 3 will be tested in cellular and in vivo
systems in collaboration with Project 2 for their possible contribution to the immunogenicity of fVIII.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling the immune response to factor VIII
-
批准号:10406900
-
项目类别:
-
资助金额:$161.33万
-
财政年份:2018
-
负责人:John S. Lollar
-
依托单位:
Unraveling the immune response to factor VIII
-
批准号:9522256
-
项目类别:
-
资助金额:$164.03万
-
财政年份:2018
-
负责人:John S. Lollar
-
依托单位:
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia
-
批准号:8464235
-
项目类别:
-
资助金额:$49.64万
-
财政年份:2013
-
负责人:John S. Lollar
-
依托单位:
Molecular Heterogeneity in FVIII Inhibitor Patients
-
批准号:8464234
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2013
-
负责人:John S. Lollar
-
依托单位:
Biorepository Core
-
批准号:8464242
-
项目类别:
-
资助金额:$20.77万
-
财政年份:2013
-
负责人:John S. Lollar
-
依托单位:
The Immune Response to Factor Vlll
-
批准号:8391965
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Eradication of FVIII Inhibitors using Gene-Based Therapy
-
批准号:8391966
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Biological Variation in Hemophilia
-
批准号:8464228
-
项目类别:
-
资助金额:$231.64万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Biological Variation in Hemophilia
-
批准号:8656781
-
项目类别:
-
资助金额:$243.49万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Biorepository Core
-
批准号:8392594
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Molecular Heterogeneity in FVIII Inhibitor Patients
-
批准号:8391968
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Administrative Core
-
批准号:8392589
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Biological Variation in Hemophilia
-
批准号:8250499
-
项目类别:
-
资助金额:$252.33万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia
-
批准号:8391969
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Animal Core
-
批准号:8392592
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Translational Research Skills
-
批准号:8392591
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
Biological Variation in Hemophilia
-
批准号:8845238
-
项目类别:
-
资助金额:$242.62万
-
财政年份:2012
-
负责人:John S. Lollar
-
依托单位:
The Immune Response to Factor VIII
-
批准号:7730604
-
项目类别:
-
资助金额:$48.36万
-
财政年份:2009
-
负责人:John S. Lollar
-
依托单位:
Structure and Function of the Factor VIII - von Willebrand Factor Complex
-
批准号:7851215
-
项目类别:
-
资助金额:$35.67万
-
财政年份:2009
-
负责人:John S. Lollar
-
依托单位:
Structure and Function of the Factor VIII - von Willebrand Factor Complex
-
批准号:7583516
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2009
-
负责人:John S. Lollar
-
依托单位:
海外基金